Squarepoint Ops LLC Rhythm Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$35.41 - $44.37 $2.92 Million - $3.66 Million	-82,512 Reduced 75.87%	26,243 $1.08 Million
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $3.65 Million - $4.9 Million	93,405 Added 608.5%	108,755 $4.71 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $328,336 - $761,974	15,350 New	15,350 $705,000
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $689,328 - $1.4 Million	40,837 Added 62.69%	105,975 $1.89 Million
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $158,668 - $216,106	7,144 Added 12.32%	65,138 $1.9 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $59,469 - $426,655	13,830 Added 31.32%	57,994 $1.42 Million
Q2 2022 Aug 15, 2022	BUY	$3.12 - $12.25 $92,358 - $362,624	29,602 Added 203.28%	44,164 $183,000
Q1 2022 May 16, 2022	BUY	$6.13 - $12.24 $89,265 - $178,238	14,562 New	14,562 $168,000
Q3 2021 Nov 15, 2021	SELL	$11.68 - $20.72 $240,736 - $427,059	-20,611 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.52 - $22.55 $943,279 - $1.15 Million	-50,933 Reduced 71.19%	20,611 $404,000
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $429,360 - $837,306	21,203 Added 42.12%	71,544 $1.52 Million
Q4 2020 Feb 16, 2021	BUY	$21.17 - $32.61 $848,959 - $1.31 Million	40,102 Added 391.66%	50,341 $1.5 Million
Q3 2020 Nov 16, 2020	BUY	$18.13 - $30.61 $185,633 - $313,415	10,239 New	10,239 $222,000
Q1 2020 May 15, 2020	SELL	$13.16 - $22.9 $474,773 - $826,163	-36,077 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.53 - $25.5 $264,865 - $345,831	13,562 Added 60.24%	36,077 $828,000
Q3 2019 Nov 14, 2019	BUY	$18.62 - $24.51 $419,229 - $551,842	22,515 New	22,515 $486,000
Q2 2019 Aug 14, 2019	SELL	$21.11 - $28.48 $547,698 - $738,913	-25,945 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$24.76 - $31.66 $133,505 - $170,710	-5,392 Reduced 17.21%	25,945 $711,000
Q4 2018 Feb 14, 2019	SELL	$24.11 - $31.34 $34,380 - $44,690	-1,426 Reduced 4.35%	31,337 $842,000
Q3 2018 Nov 14, 2018	BUY	$26.99 - $35.85 $371,652 - $493,654	13,770 Added 72.5%	32,763 $956,000
Q2 2018 Aug 14, 2018	BUY	$17.02 - $35.2 $323,260 - $668,553	18,993 New	18,993 $594,000

Others Institutions Holding RYTM

# of Institutions

191

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

Primecap Management CO Pasadena, CA

7.22M
Shares

$401 Million
0.28% of portfolio
Black Rock Inc. New York, NY

6.74M
Shares

$375 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

6.4M
Shares

$356 Million
3.59% of portfolio
Ra Capital Management, L.P. Boston, MA

6.08M
Shares

$338 Million
4.44% of portfolio
Goldman Sachs Group Inc New York, NY

3.88M
Shares

$216 Million
0.03% of portfolio

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.1B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account